NOWDx Submits De Novo Classification Request to the FDA for Its First to Know ™ Over-the-Counter Syphilis Test
/PRNewswire/ -- NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and...
Source: prnewswire.com